Repeated systemic administration of adipose tissue-derived mesenchymal stem cells prevents tracheal obliteration in a murine model of bronchiolitis obliterans
- 20 May 2017
- journal article
- research article
- Published by Springer Nature in Biotechnology Letters
- Vol. 39 (8) , 1269-1277
Abstract
Objective To investigate the effect of adipose tissue-derived mesenchymal stem cell (ASC) administered either systemically or locally in a murine model of bronchiolitis obliterans. Results When compared to controls, systemic treatment with 106 ASCs on D0 and a second dose on D7 significantly prevented tracheal obliteration 28 days after heterotopic tracheal transplantation (median of 94 vs. 16%; P < 0.01). A single dose tended towards less stenosis than controls, but did not reach statistical significance (28 vs. 94%; P = 0.054). On the contrary, repeated local injection was incapable of preventing tracheal obliteration when compared to a single injection or controls (37 vs. 71 vs. 87%). Two intravenous doses also tended to be better than two local injections (16 vs. 37%; P = 0.058), and were better than a single local dose (16 vs. 71%; P < 0.01). Conclusion A second dose of ASC, given systemically after 7 days, reduces luminal obliteration in a heterotopic tracheal transplantation model in mice, suggesting that ASC can be used to prevent obliterative bronchiolitis after lung transplantation.Keywords
Funding Information
- Hospital de Clínicas de Porto Alegre (12-0066)
This publication has 30 references indexed in Scilit:
- Lung re-transplantationCurrent Opinion in Organ Transplantation, 2012
- Angiopoietin-1 preconditioning enhances survival and functional recovery of mesenchymal stem cell transplantationJournal of Zhejiang University-SCIENCE B, 2012
- Dynamic culture improves MSC adhesion on freeze-dried bone as a scaffold for bone engineeringWorld Journal of Stem Cells, 2012
- Endothelin-1 Governs Proliferation and Migration of Bronchoalveolar Lavage-Derived Lung Mesenchymal Stem Cells in Bronchiolitis Obliterans SyndromeTransplantation, 2011
- Lung Transplantation: The Yin and Yang of Mesenchymal Stem CellsTransplantation, 2011
- Obliterative airway remodelling in transplanted and non-transplanted lungsVirchows Archiv, 2010
- Mesenchymal Stem Cells Modulate Lung InjuryProceedings of the American Thoracic Society, 2010
- Developing Cell Therapy Techniques for Respiratory Disease: Intratracheal Delivery of Genetically Engineered Stem Cells in a Murine Model of Airway InjuryHuman Gene Therapy, 2009
- Characterization of human adult stem‐cell populations isolated from visceral and subcutaneous adipose tissueThe FASEB Journal, 2009
- Fat tissue: an underappreciated source of stem cells for biotechnologyTrends in Biotechnology, 2006